May 4, 2020 / 1:02 PM / a month ago

BRIEF-FDA Approves Fensolvi For Injectable Suspension For Pediatric Patients With Central Precocious Puberty

May 4 (Reuters) - Tolmar Pharmaceuticals Inc:

* FDA APPROVES FENSOLVI® (LEUPROLIDE ACETATE) FOR INJECTABLE SUSPENSION FOR PEDIATRIC PATIENTS WITH CENTRAL PRECOCIOUS PUBERTY Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below